An overview of the pathogenesis of thyroid autoimmunity

Hormones

Volumn 12, Issue 1, 2013, Pages 19-29

  Cogni, Giulia ^a   Chiovato, Luca ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

Autoimmunity; Environment and thyroid autoimmunity; Experimental autoimmune thyroiditis; Genes of thyroid autoimmunity; Graves' disease; Hashimoto's thyroiditis; Thyroid; Thyroid antibodies

Indexed keywords

CD28 ANTIGEN; CD40 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; HLA A2 ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 4; INTERLEUKIN 6; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; THYROGLOBULIN; THYROTROPIN RECEPTOR; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ANTIBODY DETECTION; AUTOIMMUNITY; CD25 GENE; CD40 GENE; CELL FUNCTION; CELLULAR IMMUNITY; CTLA4 GENE; EFFECTOR CELL; ENVIRONMENTAL FACTOR; FETAL CELL MICROCHIMERISM; FOXP3 GENE; GENETIC PREDISPOSITION; GRAVES DISEASE; HASHIMOTO DISEASE; HLA DR GENE; HUMAN; HUMORAL IMMUNITY; HYGIENE HYPOTHESIS; IMMUNOGENETICS; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOGENESIS; INNATE IMMUNITY; MICROCHIMERISM; NONHUMAN; PROTEIN TYROSINE PHOSPHATASE 22 GENE; REVIEW; THYROGLOBULIN GENE; TSH RECEPTOR GENE;

EID: 84876249699     PISSN: 11093099     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03401283     Document Type: Review

References (52)

1. Stathatos N, Daniels GH, 2012 Autoimmune thyroid disease. Curr Opin Rheumatol 24: 70-75.
2. Rose NR, Bona C, 1993 Defining criteria for autoimmune diseases (Witebsky's postulates revisited). Immunol Today 14: 426-430.
3. Weetman AP, 2003 The mechanisms of autoimmunity in endocrinology: application to the thyroid gland. Ann Endocrinol (Paris) 64: 26-27.
4. Tonacchera M, Agretti P, Ceccarini G, et al, 2001 Autoantibodies from patients with autoimmune thyroid disease do not interfere with the activity of the human iodide symporter gene stably transfected in CHO cells. Eur J Endocrinol 144: 611-618.
5. Yoshida A, Hisatome I, Taniguchi S, et al, 2009 Pendrin is a novel autoantigen recognized by patients with autoimmune thyroid diseases. J Clin Endocrinol Metab 94: 442-448.
6. Ganesh BB, Bhattacharya P, Gopisetty A, Prabhakar BS, 2011 Role of cytokines in the pathogenesis and suppression of thyroid autoimmunity. J Interferon Cytokine Res 31: 721-731.
7. Vasu C, Dogan RN, Holterman MJ, Prabhakar BS, 2003 Selective induction of dendritic cells using granulocyte macrophagecolony stimulating factor, but not fms-like tyrosine kinase receptor 3-ligand, activates thyroglobulin-specific CD4+ /CD25 + T cells and suppresses experimental autoimmune thyroiditis. J Immunol 170: 5511-5522.
8. Kroemer G, Hirsch F, Gonzalez-Garcia A, Martinez C, 1996 Differential involvement of Th1 and, Th2 cytokines in autoimmune diseases. Autoimmunity 24: 25-33.
9. Langrish CL, et al, 2005 IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 201: 233-240.
10. Yoshimoto T, Takeda K, Tanaka T, et al, 1998 IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-gamma production. J Immunol 161: 3400-3407.
11. Kong YC, Morris GP, Brown NK, Yan Y, Flynn JC, David CS, 2009 Autoimmune thyroiditis: a model uniquely suited to probe regulatory T cell function. J Autoimmun 33: 239-246.
12. Gangi E, Vasu C, Cheatem D, Prabhakar BS, 2005 IL- 10-producing CD4+CD25+ regulatory T cells play a critical role in granulocyte-macrophage colony-stimulating factor-induced suppression of experimental autoimmune thyroiditis. J Immunol 174: 7006-7013.
13. Quaratino S, Badami E, Pang YY, et al, 2004 Degenerate self-reactive human T-cell receptor causes spontaneous autoimmune disease in mice. Nat Med 10: 920-926.
14. Ehlers M, Thiel A, Bernecker C, et al, 2012 Evidence of a combined cytotoxic thyroglobulin and thyroperoxidase epitope-specific cellular immunity in Hashimoto's thyroiditis. J Clin Endocrinol Metab 97: 1347-1354.
15. Rotondi M, Chiovato L, Romagnani S, Serio M, Romagnani P, 2007 Role of chemokines in endocrine autoimmune diseases. Endocr Rev 28: 492-520.
16. Tomer Y, Huber A, 2009 The etiology of autoimmune thyroid disease: a story of genes and environment. J Autoimmun 32: 231-239.
17. Mariotti S, Chiovato L, Vitti P, et al, 1989 Recent advances in the understanding of humoral and cellular mechanisms implicated in thyroid autoimmune disorders. Clin Immunol Immunopathol 50(1 Pt 2): S73-84.
18. Chiovato L, Bassi P, Santini F, et al, 1993 Antibodies producing complement-mediated thyroid cytotoxicity in patients with atrophic or goitrous autoimmune thyroiditis. J Clin Endocrinol Metab 77: 1700-1705.
19. Dayan CM, Daniels GH, 1996 Chronic autoimmune thyroiditis. N Engl J Med 335: 99-107.
20. Bartalena L, Tanda ML N, 2009 Clinical practice. Graves' ophthalmopathy. Engl J Med 360: 994-1001.
21. Wiersinga WM, 2011 Autoimmunity in Graves' ophthalmopathy: the result of an unfortunate marriage between TSH receptors and IGF-1 receptors? J Clin Endocrinol Metab 96: 2386-2394.
22. Marino M, Chiovato L, Pinchera A 2006 Graves' disease. In: DeGroot LJ and Jameson JL, Endocrinology, Elsavier, Philadelphia; pp. 1995-2028.
23. Caturegli P, Kimura H, 2010 A nonclassical model of autoimmune hypothyroidism. Thyroid 20: 3-5.
24. Duntas LH, 2008 Environmental factors and autoimmune thyroiditis. Nat Clin Pract Endocrinol Metab 4: 454-460.
25. Tomer Y, 2010 Genetic susceptibility to autoimmune thyroid disease: past, present, and future. Thyroid 20: 715-725.
26. Brix TH, Kyvik KO, Hegedus L, 2000 A populationbased study of chronic autoimmune hypothyroidism in Danish twins. J Clin Endocrinol Metab 85: 536-539.
27. Brix TH, Kyvik KO, Christensen K, Hegedus L, 2001 Evidence for a major role of heredity in Graves' disease: a population-based study of two Danish twin cohorts. J Clin Endocrinol Metab 86: 930-934.
28. Kawashima A, Tanigawa K, Akama T, Yoshihara A, Ishii N, Suzuki K, 2011 Innate immune activation and thyroid autoimmunity. J Clin Endocrinol Metab 96: 3661-3671.
29. Barbesino G, Chiovato L, 2000 The genetics of Hashimoto's disease. Endocrinol Metab Clin North Am 29: 357-374.
30. Dustin ML, 2008 T-cell activation through immunological synapses and kinapses. Immunol Rev 221: 77-89.
31. Ban Y, Davies TF, Greenberg DA, et al, 2004 Arginine at position 74 of the HLA-DRb1 chain is associated with Graves' disease. Genes Immun 5: 203-208.
32. Armitage RJ, Macduff BM, Spriggs MK, Fanslow WC, 1993 Human B cell proliferation and Ig secretion induced by recombinant CD40 ligand are modulated by soluble cytokines. J Immunol 150: 3671-3680.
33. Arpin C, Déchanet J, Van Kooten C, et al, 1995 Generation of memory B cells and plasma cells in vitro. Science 268: 720-722.
34. Teft WA, Kirchhof MG, Madrenas J, 2006 A molecular perspective of CTLA-4 function. Annu Rev Immunol 24: 65-97.
35. Cloutier JF, Veillette A, 1999 Cooperative inhibition of T-cell antigen receptor signaling by a complex between a kinase and a phosphatase. J Exp Med 189: 111-121.
36. Davies TF, 2007 Really significant genes for autoimmune thyroid disease do not exist--so how can we predict disease? Thyroid 17: 1027-1029.
37. Anderson MS, 2008 Update in endocrine autoimmunity. J Clin Endocrinol Metab 93: 3663-3670.
38. Cetani F, Barbesino G, Borsari S, et al, 2001 A novel mutation of the autoimmune regulator gene in an Italian kindred with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy, acting in a dominant fashion and strongly cosegregating with hypothyroid autoimmune thyroiditis. J Clin Endocrinol Metab 86: 4747-4752.
39. Hanafusa T, Pujol-Borrell R, Chiovato L, Russell RC, Doniach D, Bottazzo GF, 1983 Aberrant expression of HLA-DR antigen on thyrocytes in Graves' disease: relevance for autoimmunity. Lancet 2: 1111-1115.
40. Shimojo N, Kohno Y, Yamaguchi K, et al, 1996 Induction of Graves-like disease in mice by immunization with fibroblasts transfected with the thyrotropin receptor and a class II molecule. Proc Natl Acad Sci USA 93: 11074-11079.
41. McLachlan SM, Nagayama Y, Rapoport B, 2005 Insight into Graves' hyperthyroidism from animal models. Endocr Rev 26: 800-832.
42. Nagayama Y, 2005 Animal models of Graves' hyperthyroidism. Endocr J 52: 385-394.
43. Fugazzola L, Cirello V, Beck-Peccoz P, 2012 Microchimerism and endocrine disorders. J Clin Endocrinol Metab 97: 1452-1461.
44. Klintschar M, Schwaiger P, Mannweiler S, Regauer S, Kleiber M, 2001 Evidence of fetal microchimerism in Hashimoto's thyroiditis. J Clin Endocrinol Metab 86: 2494-2498.
45. Ando T, Imaizumi M, Graves PN, Unger P, Davies TF, 2002 Intrathyroidal fetal microchimerism in Graves' disease. J Clin Endocrinol Metab 87: 3315-3320.
46. Renne C, Ramos Lopez E, Steimle-Grauer SA, et al, 2004 Thyroid fetal male microchimerism in mothers with thyroid disorders: presence of Y-chromosomal immunofluorescence in thyroid infiltrating lymphocytes is more prevalent in Hashimoto's thyroiditis and Graves' disease than in follicular adenomas. J Clin Endocrinol Metab 89: 5810-5814.
47. Imaizumi M, Pritsker A, Unger P, Davies TF, 2002 Intrathyroidal fetal microchimerism in pregnancy and postpartum. Endocrinology 143: 247-253.
48. Friedrich N, Schwarz S, Thonack J, John U, Wallaschof- ski H, Volzke H, 2008 Association between parity and autoimmune thyroiditis in a general female population. Autoimmunity 41: 174-180.
49. Walsh JP, Bremner AP, Bulsara MK, et al, 2005 Parity and the risk of autoimmune thyroid disease: a communitybased study. J Clin Endocrinol Metab 90: 5309-5312.
50. Bulow Pedersen I, Laurberg P, Knudsen N, et al, 2006 Lack of association between thyroid autoantibodies and parity in a population study argues against microchimerism as trigger of thyroid autoimmunity. Eur J Endocrinol 154: 39-45.
51. Sgarbi JA, Kasamatsu TS, Matsumura LK, Maciel RMB, 2010 Parity is not related to autoimmune thyroid disease in a population-based study of Japanese-Brazilians. Thyroid 20: 1151-1156.
52. Kondrashova A, Viskari H, Haapala AM, et al, 2007 Serological evidence of thyroid autoimmunity among schoolchildren in two different socioeconomic environments. J Clin Endocrinol Metab 93: 729-734.